Avaliação do desempenho do BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) numa coorte brasileira de 1.492 pacientes com espondiloartrites: dados do Registro Brasileiro de Espondiloartrites (RBE)

Costa, Izaías Pereira da; Bortoluzzo, Adriana Bruscato; Gonçalves, Célio Roberto; Silva, José Antonio Braga da; Ximenes, Antônio Carlos; Bértolo, Manoel Barros; Ribeiro, Sandra Lúcia Euzébio; Keiserman, Mauro Waldemar; Menin, Rita; Skare, Thelma Larocca; Carneiro, Sueli; Azevedo, Valderílio Feijó; Vieira, Walber Pinto; Albuquerque, Elisa N.; Bianchi, W.; Bonfiglioli, Rubens; Campanholo, Cristiano; Carvalho, Hellen M.S.; Duarte, Ângela Luzia Branco Pinto; Kohem, Charles Lubianca; Leite, Nocy; Lima, Sonia A.L.; Meirelles, Eduardo S.; Pereira, Ivânio Alves; Pinheiro, Marcelo M.; Polito, Elizandra; Resende, Gustavo Gomes; Rocha, Francisco Airton Castro; Santiago, Mittermayer Barreto; Sauma, Maria de Fátima Lobato da Cunha; Valim, Valéria; Sampaio-Barros, Percival D.

doi:10.1016/j.rbr.2014.05.005

Cited by 14 publications

(2 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The BASDAI score was evolved and validated to assess the activity of ankylosing spondylitis, although as well as questions concerning the severity of axial symptoms, it includes questions about the symptoms resulting from involvement of peripheral joints (question 3) and soft tissues as enthesopathy (question 4). Da Costa et al [9] reported higher BASDAI score in patients with concomitantly active axial and peripheral symptoms (overlapping form of SpA), comparing to purely axial or peripheral disease. Taking into account higher DAS28 score in perSpA, we suppose that the reason for the higher BASDAI score in this group results just from more evident peripheral involvement, with pain and swelling of joints, and enthesopathy.…”

Section: Discussionmentioning

confidence: 99%

Results from Polish Spondyloarthritis Initiative registry (PolSPI) – methodology and data from – the first year of observation

Guła¹,

Barczyńska²,

Brzosko³

et al. 2017

Reumatologia

View full text Add to dashboard Cite

ObjectivesReport on one-year results from the Polish Spondyloarthritis Initiative registry (PolSPI), containing the cross-sectional analysis of clinical and imaging data as well as database methodology.Material and methodsThe PolSPI registry includes patients with axial (axSpA) and peripheral (perSpA) spondyloarthritis according to ASAS classification criteria, and/or patients with ankylosing spondylitis according to modified New York criteria, psoriatic arthritis according to CASPAR criteria, arthropathy in inflammatory bowel disease, reactive arthritis, juvenile spondyloarthritis or undifferentiated spondyloarthritis. Epidemiologic data and history of signs, symptoms and treatment of spondyloarthritis are collected and assessment of disease activity is performed. Radiographic images of sacroiliac joint, cervical and lumbar spine, and results of bone densitometry are collected. Every 6 months blood samples for inflammatory markers, and for long-term storage are taken.ResultsDuring a one-year period from September 2015 to August 2016, 63 patients were registered on an electronic database; 44 (69.8%) of patients were classified as axial spondyloarthritis (axSpA) and 19 (30.2%) as peripheral spondyloarthritis (perSpA) according to ASAS criteria. Statistically significant differences between axSpA and perSpA were discovered in the percentage of HLA-B27 antigen occurrence (92.6% and 50%, respectively), BASDAI (2.8% and 4.1%, respectively), DAS 28 (2.66% and 4.03%, respectively), percentage of peripheral arthritis (20% and 88.8%, respectively), enthesitis (26.7% and 70.6%, respectively), dactylitis (6.7% and 88.9%, respectively), as well as extra-articular symptoms: acute anterior uveitis (26.7% and 5.6%, respectively) and psoriasis (6.9% and 55.6%, respectively). Patients with axSpA had significantly higher mean grade of sacroiliac involvement according to New York criteria, higher mSASSS score, and lower T-score in femoral neck in bone densitometry.ConclusionsAt the early stage of the disease patients with axSpA compared to those with perSpA, have more advanced structural damage of sacroiliac joints and spine, and lower bone mineral density in the femoral neck. In the upcoming years the PolSPI registry will prospectively follow-up patients with SpA, recording response to treatment and carrying out research on interaction of inflammation and bone remodelling.

show abstract

Section: Discussionmentioning

confidence: 99%

Results from Polish Spondyloarthritis Initiative registry (PolSPI) – methodology and data from – the first year of observation

Guła¹,

Barczyńska²,

Brzosko³

et al. 2017

Reumatologia

View full text Add to dashboard Cite

show abstract

“…IBD-associated SpA can be classified into axial SpA or peripheral SpA (pSpA) (arthritis, enthesitis, or dactylitis) using diagnostic criteria established by Assessment of SpondyloArthritis International Society (ASAS). 3 Validated clinical SpA disease activity indices are crucial to longitudinally track the response of SpA symptoms in a clinical setting 4 , 5 . The aim of this study was to apply SpA diagnostic criteria and disease activity indices to assess intestinal and joint response to biologic therapy in IBD subjects with pSpA.…”

mentioning

confidence: 99%

Joint Disease Activity in Inflammatory Bowel Disease–associated Peripheral Spondyloarthritis Stratifies Therapeutic Response

Lai

Funez-dePagnier

Duenas-Bianchi

et al. 2022

Gastro Hep Advances

View full text Add to dashboard Cite

Defining the phenotype, pathogenesis and treatment of Crohn’s disease associated spondyloarthritis

et al. 2020

View full text Add to dashboard Cite

Peripheral and axial spondyloarthritis are the most common extra-intestinal manifestations reported in patients with Crohn’s disease. Despite the frequency of Crohn’s disease associated spondyloarthritis, clinical diagnostic tools are variably applied in these cohorts and further characterization with validated spondyloarthritis disease activity indexes are needed. In addition, the pathogenesis of Crohn’s disease associated spondyloarthritis is not well understood. Evidence of shared genetic, cellular, and microbial mechanisms underlying both Crohn’s disease and spondyloarthritis highlight the potential for a distinct clinicopathologic entity. Existing treatment paradigms for Crohn’s disease associated spondyloarthritis focus on symptom control and management of luminal inflammation. A better understanding of the underlying pathogenic mechanisms in Crohn’s disease associated spondyloarthritis and the link between the gut microbiome and systemic immunity will help pave the way for more targeted and effective therapies. This review highlights recent work that has provided a framework for clinical characterization and pathogenesis of Crohn’s disease associated spondyloarthritis and helps identify critical gaps that will help shape treatment paradigms.

show abstract

Avaliação do desempenho do BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) numa coorte brasileira de 1.492 pacientes com espondiloartrites: dados do Registro Brasileiro de Espondiloartrites (RBE)

Abstract: In this heterogeneous Brazilian series of SpA patients, BASDAI was able to demonstrate "disease activity" in patients with axial as well as peripheral disease.

Cited by 14 publications

References 24 publications

Results from Polish Spondyloarthritis Initiative registry (PolSPI) – methodology and data from – the first year of observation

Results from Polish Spondyloarthritis Initiative registry (PolSPI) – methodology and data from – the first year of observation

Joint Disease Activity in Inflammatory Bowel Disease–associated Peripheral Spondyloarthritis Stratifies Therapeutic Response

Defining the phenotype, pathogenesis and treatment of Crohn’s disease associated spondyloarthritis

Contact Info

Product

Resources

About